Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Horby, Peter, Lim, Wei Shen, Emberson, Jonathan, Mafham, Marion, Bell, Jennifer, Linsell, Louise, Staplin, Natalie, Brightling, Christopher +19 more·2020·New England Journal of Medicine
DOI 10.1101/2020.06.22.20137273

Cited by (1,004)

Items 301–400 of 1,004

  1. Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
    D. Meekins, N. Gaudreault, J. Richt · 2021 · Viruses
  2. Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies
    Claudio Doglioni, Claudia Ravaglia, Marco Chilosi, Giulio Rossi, Alessandra Dubini, Federica Pedica, Sara Piciucchi, Antonio Vizzuso, Franco Stella, Stefano Maitan et al. · 2021 · Respiration
  3. Acute and Post-Acute Neurological Complications of COVID-19
    Ali Al-Ramadan, Omar Rabab’h, Jawad Shah, Abeer Gharaibeh · 2021 · Neurology International
  4. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
    Peter Andrew McCullough, Paul Elias Alexander, Robin Armstrong, Cristian Arvinte, A. Bain, Richard P. Bartlett, Robert L. Berkowitz, Andrew C. Berry, Thomas Julius Borody, Joseph Brewer et al. · 2020 · Reviews in Cardiovascular Medicine
  5. Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses
    Ji‐Soo Kwon, Ji Yeun Kim, Min‐Chul Kim, Se Yoon Park, Baek-Nam Kim, Seongman Bae, Hye Hee Cha, Jiwon Jung, Minjae Kim, Myung Jin Lee et al. · 2020 · American Journal of Tropical Medicine and Hygiene
  6. Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019–Related Respiratory Failure*
    Kusum S. Mathews, Howard Soh, Shahzad Shaefi, Wei Wang, Sonali Bose, Steven G. Coca, Shruti Gupta, Salim S. Hayek, Anand Srivastava, Samantha K. Brenner et al. · 2021 · Critical Care Medicine
  7. COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
    Anup Singh Pathania, Philip Prathipati, Bakrudeen AA. Abdul, Srinivas Prabhu Chava, Santharam S. Katta, Subash Chandra Gupta, Pandu R. Gangula, Manoj Kumar Pandey, Donald L. Durden, Siddappa N. Byrareddy et al. · 2020 · Theranostics
  8. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
    Edward Burn, Seng Chan You, Anthony G. Sena, Kristin Kostka, Hamed Abedtash, Maria Tereza Fernandes Abrahão, Amanda Alberga, Heba Alghoul, Osaid H. Alser, Thamir M. Alshammari et al. · 2020 · Nature Communications
  9. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome—An Observational Pilot Study
    Quirin Notz, Marc Schmalzing, Florian Wedekink, Tobias Schlesinger, Michael Gernert, Johannes Herrmann, Lena Sorger, Dirk Weismann, Benedikt Schmid, Magdalena Sitter et al. · 2020 · Frontiers in Immunology
  10. Pros and cons of corticosteroid therapy for COVID-19 patients
    Paula Mattos-Silva, Nathane Santanna Felix, Pedro Leme Silva, Chiara Robba, Denise Battaglini, Paolo P. Pelosi, Patrícia R. M. Rocco, Fernanda Ferreira Cruz · 2020 · Respiratory Physiology & Neurobiology
  11. Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19: a case series
    X. Solanich, Gardenia Vargas-Parra, C. I. van der Made et al. · 2021 · medRxiv
  12. Invasive mould disease in fatal COVID-19: a systematic review of autopsies
    Brittany Kula, Cornelius Joseph Clancy, M. Hong Nguyen, Ilan Steven Schwartz · 2021 · The Lancet Microbe
  13. Respiratory viral infections in the elderly
    Alastair Watson, Tom M. A. Wilkinson · 2021 · Therapeutic Advances in Respiratory Disease
  14. CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS
    Mathieu Blot, Marine Jacquier, Serge Aho, Guillaume Beltramo, Maxime Nguyen, Philippe Bonniaud, Sébastien Prin, Pascal Andreu, Bélaïd Bouhemad, Jean‐Baptiste Bour et al. · 2020 · Critical Care
  15. Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future
    Brian Godman, Mainul Haque, Salequl Islam, Samiul Iqbal, Umme Laila Urmi, Zubair Mahmood Kamal, Shahriar Nasim Shuvo, Aminur Rahman, Mustafa Kamal, Monami Haque et al. · 2020 · Frontiers in Public Health
  16. Associations between COVID-19-Related Digital Health Literacy and Online Information-Seeking Behavior among Portuguese University Students.
    Rosário, Rafaela, Martins, Maria R. O., Augusto, Cláudia, Silva, Maria José, Martins, Silvana, Duarte, Ana, Fronteira, Inês, Ramos, Neida, Okan, Orkan, Dadaczynski, Kevin · 2020 · International Journal of Environmental Research and Public Health
  17. Corticosteroids for COVID-19: the search for an optimum duration of therapy
    Gyanshankar Mishra, Jasmin Mulani · 2020 · The Lancet Respiratory Medicine
  18. Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
    Chandan Kumar Sarkar, Milon Mondal, Muhammad Torequl Islam, Miquel Martorell, Anca Oana Docea, Alfred Maroyi, Javad Sharifi‐Rad, Daniela Cornelia Călina · 2020 · Frontiers in Pharmacology
  19. COVID‐19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays
    Xueqing Wang, Yuanfang Guan · 2020 · Medicinal Research Reviews
  20. Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
    Calum T. Robb, Marie Goepp, Adriano Giorgio Rossi, Chengcan Yao · 2020 · British Journal of Pharmacology
  21. The Circadian Clock and Viral Infections
    Helene Borrmann, Jane A. McKeating, Xiaodong Alan Zhuang · 2020 · Journal of Biological Rhythms
  22. Cytokine Storms in Cancer and COVID-19
    Casmir Turnquist, B. Ryan, I. Horikawa, B. T. Harris, C. Harris · 2020 · Cancer Cell
  23. Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
    Janine Alessi, Giovana Berger de Oliveira, Beatriz D'Agord Schaan, Gabriela Heiden Teló · 2020 · Diabetology & Metabolic Syndrome
  24. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
    Vincenzo Montesarchio, Roberto Parrella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna Carmela De Rosa et al. · 2020 · Journal for ImmunoTherapy of Cancer
  25. Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
    Alejandro Piscoya, Luis Fernando Ng-Sueng, Angela Parra del Riego, Renato Cerna-Viacava, Vinay Pasupuleti, Yuani M. Roman, Priyaleela Thota, Charles Michael White, Adrián Vladimir Hernández · 2020 · PLoS ONE
  26. Myocarditis associated with Covid‐19 disease: A systematic review of published case reports and case series
    Sawai Singh Rathore, Gianpier Alonzo Rojas, Manush Sondhi, Suveenkrishna Pothuru, Reshma Pydi, Neeraj Kancherla, Romil Singh, Noman Khurshid Ahmed, Jill Shah, Sohaib Tousif et al. · 2021 · International Journal of Clinical Practice
  27. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
    Sophie Juul, Emil Eik Nielsen, Joshua Buron Feinberg, Faiza Siddiqui, Caroline Barkholt Kamp, Emily Barot, Niklas Nielsen, Peter Bentzer, Areti Angeliki Veroniki, Lehana Thabane et al. · 2020 · PLoS Medicine
  28. Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches
    Jesús Beltrán-García, Rebeca Osca-Verdegal, Federico Vicente Pallardó, José Ferreres, María del Pilar Rodríguez, Sandra Mulet, Carolina Ferrando-Sánchez, Nieves Carbonell, Jose Luis García‐Giménez · 2020 · Critical Care Medicine
  29. Pandemics and maternal health: the indirect effects of COVID‐19
    Lucas, D. N., Bamber, J. H. · 2021 · Anaesthesia
  30. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic
    Naomi J. Serling-Boyd, Kristin M. D’Silva, Tiffany Y. T. Hsu, Rachel S. Wallwork, Xiaoqing Fu, Ellen M. Gravallese, April M Jorge, Yuqing Zhang, Hyon K. Choi, Jeffrey A. Sparks et al. · 2020 · Annals of the Rheumatic Diseases
  31. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations
    Hoang Linh Nguyen, Nguyen Quoc Thai, Duc Toan Truong, Mai Suan Li · 2020 · The Journal of Physical Chemistry B
  32. Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients
    Ganpat Devpura, Balvir Singh Tomar, Deepak Nathiya, Abhishek Sharma, Deepak Bhandari, Swati Haldar, Acharya Balkrishna, Anurag Varshney · 2021 · Phytomedicine
  33. Potential Interaction Between SARS-CoV-2 and Thyroid: A Review
    Wenjie Chen, Yuang Tian, Zhihui Li, Jingqiang Zhu, Tao Wei, Jianyong Lei · 2021 · Endocrinology
  34. Safety of Remdesivir in Patients With Acute Kidney Injury or CKD
    Sayali B. Thakare, Chintan Gandhi, Tulsi Modi, Sreyashi Bose, Satarupa Deb, Nikhil Saxena, Abhinav Katyal, Ankita Patil, Sunil KG Patil, Atim E. Pajai et al. · 2020 · Kidney International Reports
  35. Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality
    Justin M. Snider, Jeehyun Karen You, Xia Wang, Ashley J. Snider, Brian Hallmark, Manja M. Zec, Michael C. Seeds, Susan Sergeant, Laurel M. Johnstone, Qiuming Wang et al. · 2021 · Journal of Clinical Investigation
  36. Haemophagocytic syndrome and COVID-19
    Soledad Retamozo, Pilar Brito‐Zerón, Antoni Sisó‐Almirall, Alejandra Flores-Chávez, M.J. Soto Cárdenas, Manuel Ramos‐Casals · 2021 · Clinical Rheumatology
  37. The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
    Mathieu Blot, Jean‐Baptiste Bour, Jean‐Pierre Quenot, Abderrahmane Bourredjem, Maxime Nguyen, Julien Guy, Serge Monier, Marjolaine Georges, Audrey Large, Auguste Dargent et al. · 2020 · Journal of Translational Medicine
  38. Nanotechnology for virus treatment
    Jiarong Zhou, Nishta Krishnan, Yao Jiang, Ronnie H. Fang, Liangfang Zhang · 2020 · Nano Today
  39. Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials
    Laura Pasin, Paolo Navalesi, Alberto Zangrillo, Artem N. Kuzovlev, Valery V. Likhvantsev, Ludhmila Abrahão Hajjar, Stefano Fresilli, Marcus Lacerda, Giovanni Landoni · 2020 · Journal of Cardiothoracic and Vascular Anesthesia
  40. Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management
    Matthew L. Dove, Preeti Jaggi, Michael Scott Kelleman, Mayssa M. Abuali, Jocelyn Y. Ang, Wassim M. Ballan, Sanmit K. Basu, Michael Jay Campbell, Sathish Mallenahalli Chikkabyrappa, Nadine F. Choueiter et al. · 2020 · The Journal of Pediatrics
  41. Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options?
    Urban Hellman, Mats G. Karlsson, Anna Engström‐Laurent, Sara Cajander, Luiza Dorofte, Clas Ahlm, Claude Laurent, Anders Blomberg · 2020 · Journal of Biological Chemistry
  42. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme
    Giuseppe Lisco, Anna De Tullio, Assunta Stragapede, Antonio Giovanni Solimando, Federica Albanese, Martina Capobianco, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Angelo Vacca et al. · 2021 · Journal of Clinical Medicine
  43. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression
    Angelo Zinellu, Arduino Aleksander Mangoni · 2021 · Frontiers in Immunology
  44. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Omkar Indari, Shweta Jakhmola, Elangovan Manivannan, Hem Chandra Jha · 2021 · Frontiers in Pharmacology
  45. Tackling the cytokine storm in COVID-19, challenges and hopes
    Shifaa M. Abdin, Sara M. Elgendy, Shatha K. Alyammahi, Dima W. Alhamad, Hany A. Omar · 2020 · Life Sciences
  46. Characteristics of viral pneumonia in the COVID-19 era: an update
    Pasquale Pagliano, Carmine Sellitto, Valeria Conti, Tiziana Ascione, Silvano Esposito · 2021 · Infection
  47. Navigating the Uncertainties of COVID-19–Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
    Frédéric Lamoth, Russell Edward Lewis, Thomas J. Walsh, Dimitrios P. Kontoyiannis · 2021 · The Journal of Infectious Diseases
  48. The effects of wearing facemasks on oxygenation and ventilation at rest and during physical activity
    Steven L. Shein, Sofie Whitticar, Kira Mascho, Elizabeth Pace, Richard H. Speicher, Kathleen Deakins · 2021 · PLoS ONE
  49. Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission
    Laurent Truffaut, Lucas Demey, Anne-Violette Bruyneel, Alain Roman, Stéphane Alard, Nathalie De Vos, Marie Bruyneel · 2021 · Respiratory Research
  50. In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
    Anisha S Jain, Sushma Pradeep, Chandan Dharmashekar, Mallikarjun S Beelagi, Shashanka K. Prasad, Chandan Shivamallu, Ashwini Prasad, Asad Syed, Najat Marraiki, Kollur Shiva Prasad · 2020 · Saudi Journal of Biological Sciences
  51. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Mohammed Ahmed Garout, Ayman M. Al‐Qaaneh, Anupam Ashutosh Sule, Raghavendra Tirupathi, Abbas Saleh Al Mutair, Saad Alhumaid, Abdulkarim Hasan, Manish K. Dhawan et al. · 2021 · Pathogens
  52. Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
    María Elvira Balcells, Luis E. Rojas, Nicole Le Corre, Constanza Martínez-Valdebenito, María Elena Ceballos, Marcela Ferrés G, Mayling Chang, Cecilia Vizcaya, Sebastián Mondaca, Alvaro Huete G et al. · 2021 · PLoS Medicine
  53. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
    Nicolas de Prost, Paul Bastard, Romain Arrestier, Slim Fourati, Mathieu Mahévas, Sonia Burrel, Karim Dorgham, Guy Gorochov, Yacine Tandjaoui-Lambiotte, Imane Azzaoui et al. · 2021 · Journal of Clinical Immunology
  54. Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area
    Amol A. Verma, Tejasvi Hora, Hae Young Jung, Michael Fralick, Sarah L. Malecki, Lauren Lapointe‐Shaw, Adina S. Weinerman, Terence Tang, Janice L. Kwan, Jessica Janine Liu et al. · 2021 · Canadian Medical Association Journal
  55. A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome
    Doyeon Kim, Sukjun Kim, Joori Park, Hee Ryung Chang, Jeeyoon Chang, Junhak Ahn, Heedo Park, June‐Hee Park, Narae Son, Gihyeon Kang et al. · 2021 · Nature Communications
  56. Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis
    Radha Gopalaswamy, Selvakumar Subbian · 2021 · International Journal of Molecular Sciences
  57. Risk of adverse coronavirus disease 2019 outcomes for people living with HIV
    Maya M. Mellor, Anne C. Bast, Nicholas Robert Jones, Nia Wyn Roberts, José Manuel Ordóñez-Mena, Alastair J.M. Reith, Christopher Butler, Philippa Clare Matthews, Jienchi Dorward · 2021 · AIDS
  58. COVID-19: neonatal–perinatal perspectives
    On behalf of the Harvard Neonatal-Perinatal Fellowship COVID-19 Working Group, Barrero-Castillero, Alejandra, Beam, Kristyn S., Bernardini, Laura B., Ramos, Erika G. Cordova, Davenport, Patricia E., Duncan, Anna R., Fraiman, Yarden S., Frazer, Lauren C., Healy, Helen et al. · 2021 · Journal of Perinatology
  59. Is the Frequency of Candidemia Increasing in COVID-19 Patients Receiving Corticosteroids?
    Cezar Vinícius Würdig Riche, Renato Cassol, Alessandro Comarú Pasqualotto · 2020 · Journal of Fungi
  60. COVID-19-Associated Subacute Thyroiditis: Evidence-Based Data From a Systematic Review
    Pierpaolo Trimboli, Carlo Cappelli, Laura Croce, Lorenzo Scappaticcio, Luca Chiovato, Mario Rotondi · 2021 · Frontiers in Endocrinology
  61. The role of CD4<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment
    Wang, Yifei, Zheng, Jingbin, Islam, Md Sahidul, Yang, Yang, Hu, Yuanjia, Chen, Xin · 2021 · International Journal of Biological Sciences
  62. Acute covid-19 and multisystem inflammatory syndrome in children
    Jessica H. Rubens, Nadine Peart Akindele, Megan M. Tschudy, Anna C. Sick-Samuels · 2021 · BMJ
  63. Ozone-Induced Oxidative Stress, Neutrophilic Airway Inflammation, and Glucocorticoid Resistance in Asthma
    Chioma Enweasor, Cameron H. Flayer, Angela Haczku · 2021 · Frontiers in Immunology
  64. Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies
    Cornelius Joseph Clancy, Ilan Steven Schwartz, Brittany Kula, M. Hong Nguyen · 2021 · Open Forum Infectious Diseases
  65. Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results
    Ahmad Ameri, Nazanin Rahnama, Rama Bozorgmehr, Majid Mokhtari, Mohammad Farahbakhsh, Mahmood Nabavi, ‪Simin Dokht Shoaei, Hossein Izadi, Amir Shahram Yousefi Kashi, Hadiseh Shabanpour Dehbsneh et al. · 2020 · International Journal of Radiation Oncology*Biology*Physics
  66. High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: Results from the Brazilian multicenter cohort study
    Lúcio Requião‐Moura, Tainá Veras de Sandes‐Freitas, Laila Almeida Viana, Marina Pontello Cristelli, Luís Gustavo Modelli de Andrade, Valter Duro Garcı́a, Cláudia Maria Costa de Oliveira, Ronaldo de Matos Esmeraldo, Mário Abbud‐Filho, Álvaro Pacheco‐Silva et al. · 2021 · PLoS ONE
  67. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death
    Jack Gisby, Candice Clarke, Nicholas Medjeral‐Thomas, Talat H. Malik, Artemis Papadaki, Paige M Mortimer, Norzawani B Buang, Shanice Lewis, Marie Pereira, Frédéric Toulza et al. · 2021 · eLife
  68. COVID‐19‐induced endotheliitis: emerging evidence and possible therapeutic strategies
    Eleonora Calabretta, Jose Maria Moraleda, Massimo Iacobelli, Rubén Jara, Israël Vlodavsky, Peter O’Gorman, Antonio Pagliuca, Clifton Craig Mo, Rebecca Marlene Baron, Alessio Aghemo et al. · 2021 · British Journal of Haematology
  69. Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic
    Aidan J. C. Burrell, Breanna Pellegrini, Farhad Salimi, Husna Begum, Tessa Broadley, Lewis T. Campbell, Allen C Cheng, Winston Cheung, David James Cooper, Arul Earnest et al. · 2020 · The Medical Journal of Australia
  70. Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective
    Charis Wong, Maria Stavrou, Elizabeth Elliott, Jenna M. Gregory, Nigel P. Leigh, Ashwin Arnold Pinto, Timothy L. Williams, Jeremy Chataway, Robert J Swingler, Mahesh Parmar et al. · 2021 · Brain Communications
  71. Epithelial Cells and Inflammation in Pulmonary Wound Repair
    Amanda Croasdell Lucchini, Naomi N. Gachanja, A. Rossi, D. Dorward, Christopher D. Lucas · 2021 · Cells
  72. Immunity and inflammatory biomarkers in COVID‐19: A systematic review
    Ana Paula Diniz Iwamura, Marielen R. Tavares da Silva, Ana Luísa Hümmelgen, Paulo V.S. Pereira, Ângela Falcai, Anete Sevciovic Grumach, Ekaterini Goudouris, Antônio Condino‐Neto, Carolina Prando · 2020 · Reviews in Medical Virology
  73. Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
    Daniel Pedro Cardinali, Gregory M. Brown, Seithikurippu Ratnas Pandi-Perumal · 2020 · Diseases
  74. Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
    Luigi Brunetti, Oumou Diawara, Andrew Tsai, Bonnie L. Firestein, Ronald Nahass, George J. Poiani, Naomi Schlesinger · 2020 · Journal of Clinical Medicine
  75. Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID‐19‐associated thrombopathy
    Antoine Caillon, Antonin Trimaille, Julie Favre, Laurence Jesel, Olivier Morel, Gilles Kauffenstein · 2021 · Journal of Thrombosis and Haemostasis
  76. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
    Phil‐Robin Tepasse, Richard Vollenberg, Manfred Fobker, Iyad Kabar, Hartmut Schmidt, Jörn Arne Meier, Tobias Max Nowacki, Anna Hüsing‐Kabar · 2021 · Nutrients
  77. Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19
    Evangelos Andreakos, Maria E. Papadaki, Charles Nicholas Serhan · 2020 · Allergy
  78. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge
    Pranay Sinha, Anahita Mostaghim, Catherine G. Bielick, Angela L. McLaughlin, Davidson Howes Hamer, Lee Mark Wetzler, Nahid Bhadelia, Maura A. Fagan, Benjamin Paul Linas, Sabrina A. Assoumou et al. · 2020 · International Journal of Infectious Diseases
  79. Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
    Qiu Wei, Lin Hua, Rongguo Wei, Nian Chen, Fan He, Dong-Hua Zou, Jinru Wei · 2021 · Infectious Diseases of Poverty
  80. Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
    Finny S. Varghese, Esther van Woudenbergh, Gijs J. Overheul, Marc J. Eleveld, Lisa Kurver, Niels van Heerbeek, Arjan van Laarhoven, Pascal Miesen, Gerco den Hartog, Marien Isaäk de Jonge et al. · 2021 · Viruses
  81. Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications
    Jaykaran Charan, Rimple Jeet Kaur, Pankaj Bhardwaj, Mainul Haque, Praveen Sharma, Sanjeev Misra, Brian Godman · 2020 · Expert Review of Clinical Pharmacology
  82. Loss of Olfactory Function—Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders
    Heike Rebholz, Ralf J. Braun, Dennis Ladage, Wolfgang Knoll, Christoph Kleber, Achim Walter Hassel · 2020 · Frontiers in Neurology
  83. COVID-19—Lessons Learned and Questions Remaining
    Ferric C. Fang, Constance Ann Benson, Carlos del Rı́o, Kathryn M. Edwards, Vance G. Fowler, David N. Fredricks, Ajit P. Limaye, Barbara E. Murray, Susanna Naggie, Peter G. Pappas et al. · 2020 · Clinical Infectious Diseases
  84. A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
    Magnus Nakrem Lyngbakken, Jan‐Erik Berdal, Arne Nørgaard Eskesen, Dag Kvale, Inge Christoffer Olsen, Corina S. Rueegg, Anbjørg Rangberg, Christine Monceyron Jonassen, Torbjørn Omland, Helge Rørvik Røsjø et al. · 2020 · Nature Communications
  85. Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration
    Daniel Pedro Cardinali, Gregory M. Brown, Russel Joseph Reiter, Seithikurippu Ratnas Pandi-Perumal · 2020 · Sleep and Vigilance
  86. Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel
    Alice K. Pau, Judith A. Aberg, Jason Baker, Pamela S. Belperio, Craig Coopersmith, Page E. Crew, Birgit Grund, Roy M. Gulick, Carly Harrison, Arthur Y. Kim et al. · 2020 · Annals of Internal Medicine
  87. Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19
    Jonas Bovijn, Cecilia M. Lindgren, Michael Vaclav Holmes · 2020 · The Lancet Rheumatology
  88. Pregnancy and COVID ‐19: pharmacologic considerations
    Rohan D. D'Souza, Rizwana Ashraf, H. Rowe, Jonathan S. Zipursky, Lauren Clarfield, Cynthia V. Maxwell, Cristián Arzola, Stephen E. Lapinsky, Katryn Paquette, Srinivas Murthy et al. · 2020 · Ultrasound in Obstetrics and Gynecology
  89. Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: An observational comparative study using routine care data
    G. Ruiz-Irastorza, J. Pijoan, E. Bereciartua et al. · 2020 · medRxiv
  90. Clinical presentation and management of COVID ‐19
    Irani Thevarajan, Kirsty L. Buising, Benjamin C Cowie · 2020 · The Medical Journal of Australia
  91. Diabetes, obesity and COVID ‐19: A complex interplay
    Prashanth R. J. Vas, David Hopkins, Michael D Feher, Francesco Rubino, Martin Whyte · 2020 · Diabetes Obesity and Metabolism
  92. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
    Shobi Veleri · 2021 · Experimental Brain Research
  93. Comparison of COVID-19 and influenza characteristics
    Yu Bai, Xiao‐Nan Tao · 2021 · Journal of Zhejiang University SCIENCE B
  94. Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial
    Hildur H. Arnardottir, Sven‐Christian Pawelzik, Ulf Öhlund‐Wistbacka, Gonzalo Artiach, Robin Hofmann, Ingalill Reinholdsson, Frieder Braunschweig, Per Tornvall, Dorota Religa, Magnus Bäck · 2021 · Frontiers in Physiology
  95. Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome
    Marco Ranucci, Clementina Sitzia, Ekaterina Baryshnikova, Umberto Di Dedda, Rosanna Cardani, Fabio Martelli, Massimiliano Marco Corsi Romanelli · 2020 · Journal of Clinical Medicine
  96. Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature
    Anna Apostolopoulou, Zerelda Esquer Garrigos, Prakhar Vijayvargiya, Alexis Hope Lerner, Dimitrios Farmakiotis · 2020 · Diagnostics
  97. High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review
    Hiroyuki Fujii, Taisuke Tsuji, Tatsuya Yuba, Shunya Tanaka, Yoshifumi Suga, Aosa Matsuyama, Ayaka Omura, Shinsuke Shiotsu, Chieko Takumi, Seiko Ono et al. · 2020 · Clinical Rheumatology
  98. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
    Praveen Mathews Varghese, Anthony George Tsolaki, Hadida Yasmin, Abhishek Shastri, Janez Ferluga, Manu Vatish, Taruna Madan, Uday Kishore · 2020 · Immunobiology
  99. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
    Omar Hasan Ali, David Bomze, Lorenz Risch, Silvio D. Brugger, Matthias Paprotny, Myriam C. Weber, Sarah L. Thiel, Lukas Kern, Werner C. Albrich, Philipp P. Kohler et al. · 2020 · Clinical Infectious Diseases
  100. Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study
    Lihua Zhang, Xin Zheng, Xueke Bai, Qīng Wáng, Bowang Chen, Haibo Wang, Jiapeng Lu, Shuang Hu, Xiaoyan Zhang, Haibo Zhang et al. · 2021 · Phytomedicine